Any current/future new fundraising through debt or equity?

The transcript does not mention any current or planned fundraising through debt or equity. There is no specific discussion about raising capital via new debt or equity issuance. The company is focusing on a Rs. 200 crore CAPEX largely funded internally, mainly for backward integration and capacity expansion. The management emphasizes improving working capital and cash conversion cycle to support operations. No explicit reference to equity or debt financing plans was provided in the Q2 FY24 earnings call transcript.

Any current/future capex/capital investment/strategic investment?

Best Agrolife has announced a total CAPEX of approximately Rs. 200 crores for the full year. Around Rs. 130 crores of this CAPEX is expected to be spent by year-end FY24. Majority (about Rs. 150 crores) of the CAPEX will be allocated to backward integration projects focusing on "Make in India" for strobin chemistry products. Remaining CAPEX will be used for capacity addition in formulation, including the recent acquisition of Kashmir Chemical (formulation manufacturing). The CAPEX aims to expand manufacturing capacity to meet growing demand for branded agrochemical formulation products. This i

Future growth expectations in sales/revenue/volumes?

The company targets a revenue growth of 25% to 30% year-on-year for FY24 and beyond. Formulation segment (branded products) contribution has increased to over 70%, indicating strong growth drivers. Volume growth for key products last year was around 30%, with expected continued growth. Upcoming patented molecules and new products like Orisulam (seed treatment) are expected to fuel future growth. The company is investing heavily in field assistance (~1,000+ field staff) and marketing to drive farmer adoption. Export revenue is expected to start low (~$1 million/year initially), growing to $10-3

Future growth expectations in earnings/operating earnings/profits/EPS?

Best Agrolife targets a revenue growth of 25% to 30% for FY24, supported by new product launches and expanding market footprint. The company aims to maintain EBITDA margins around 20% despite current pricing pressures and operating expense increases. Operating expenses increased by Rs. 40 crores due to investments in R&D and marketing for upcoming patented products, which are expected to drive future growth. Backward integration CAPEX (approximately Rs. 150 crores out of Rs. 200 crores total) is expected to improve EBITDA margins by 3-5% once stabilized. Export business is expected to generate

Best AgrolifeQ2 FY24Fertilizers & Agrochemicals

Best Agrolife Q2 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹17.5P/E: 21.9Market Cap: ₹647 CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 1

Fundraise

N/A

Order

N/A

Capex

Yes

2 of 3 growth signals are positive.

Full analysis

Revenue guidance

Category 2

The company targets a revenue growth of 25% to 30% year-on-year for FY24 and beyond.
Formulation segment (branded products) contribution has increased to over 70%, indicating strong growth drivers.
Volume growth for key products last year was around 30%, with expected continued growth.
Upcoming patented molecules and new products like Orisulam (seed treatment) are expected to fuel future growth.
The company is investing heavily in field assistance (~1,000+ field staff) and marketing to drive farmer adoption.
Export revenue is expected to start low (~$1 million/year initially), growing to $10-30 million per year within 5 years through international registrations and market expansion.
CAPEX focused on backward integration and formulation capacity will support sustainable growth and improve EBITDA margins by 3-5%.
Overall, a strong product pipeline and market expansion plan underpin growth confidence.

Margin guidance

Category 1

Best Agrolife targets a revenue growth of 25% to 30% for FY24, supported by new product launches and expanding market footprint.
The company aims to maintain EBITDA margins around 20% despite current pricing pressures and operating expense increases.
Operating expenses increased by Rs. 40 crores due to investments in R&D and marketing for upcoming patented products, which are expected to drive future growth.
Backward integration CAPEX (approximately Rs. 150 crores out of Rs. 200 crores total) is expected to improve EBITDA margins by 3-5% once stabilized.
Export business is expected to generate small revenues (~$1 million annually) in the next 1-2 years, growing to $10-$20 million per year within 5 years.
The company is optimistic that cash flow and profitability will improve from Q3/Q4 FY24 onward due to product acceptance and operational efficiencies.
Innovation turnover and contribution from new branded formulations now exceed 70%, enhancing earnings quality.

See what Best Agrolife management said on margin guidance — free account, 30 seconds.

Fundraise plans

The transcript does not mention any current or planned fundraising through debt or equity.
There is no specific discussion about raising capital via new debt or equity issuance.
The company is focusing on a Rs. 200 crore CAPEX largely funded internally, mainly for backward integration and capacity expansion.
The management emphasizes improving working capital and cash conversion cycle to support operations.
No explicit reference to equity or debt financing plans was provided in the Q2 FY24 earnings call transcript.

Order book

The provided transcript and document pages from Best Agrolife Limited's Q2 FY24 Earnings Conference Call do not explicitly mention any details regarding the current or expected order book or pending orders. The discussion primarily focuses on: - Inventory details relating to intermediates and raw materials. - Growth in branded product formulations. - CAPEX planning and expected impact on EBITDA. - Revenue and margin performance. - Impact of climatic conditions and market challenges. - Strategic investments and new product launches. No specific quantitative or qualitative information on order book status or pending orders is provided in the shared material.

See what Best Agrolife management said on order book — free account, 30 seconds.

Capex plans

Yes

Best Agrolife has announced a total CAPEX of approximately Rs. 200 crores for the full year.
Around Rs. 130 crores of this CAPEX is expected to be spent by year-end FY24.
Majority (about Rs. 150 crores) of the CAPEX will be allocated to backward integration projects focusing on "Make in India" for strobin chemistry products.
Remaining CAPEX will be used for capacity addition in formulation, including the recent acquisition of Kashmir Chemical (formulation manufacturing).
The CAPEX aims to expand manufacturing capacity to meet growing demand for branded agrochemical formulation products.
This investment supports new product launches, backward integration, and increased production efficiency.
Long-term focus on backward integration is expected to improve EBITDA margins by 3% to 5%.
Ongoing strategic moves include international expansion and migration to SAP HANA S4 ERP for better operational efficiency.

Track Best Agrolife — get its next earnings analysis in your feed

How does Best Agrolife rank vs peers in Fertilizers & Agrochemicals?

Pro feature

ThisBest Agrolife

Rev 2Mar 1

See where Best Agrolife sits in Fertilizers & AgrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Best Agrolife rank in Fertilizers & Agrochemicals?

Compare Best Agrolife against every Fertilizers & Agrochemicals company (Q2 FY24) on revenue, margins and earnings-call signals.

View Fertilizers & Agrochemicals leaderboard →

What Best Agrolife's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

Advance Agrolife Ltd (Q4 FY26)
Q4 FY26 total revenue: ₹1,259.07 million, up 40% YoY (Page 24). Key concall takeaways from Advance Agrolife Ltd's Q4 FY26 earnings call — and how it ranks…
Advance Agrolife Ltd (Q1 FY27)
Q1 FY27 revenue from operations: ₹3,304 million, a 96% year-on-year (YoY) increase (Page 23, 25, 22). Key concall takeaways from Advance Agrolife Ltd's Q1 FY27…
Bhagiradha Chemicals & Industries Ltd (Q4 FY26)
158.1 crores . Key concall takeaways from Bhagiradha Chemicals & Industries Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
Bhagiradha Chemicals & Industries Ltd (Q1 FY27)
195.0 crore . Key concall takeaways from Bhagiradha Chemicals & Industries Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

Compare:vs Coromandel International Ltd vs Fertilizers & Chemicals Travancore Ltd vs UPL

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →